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Abstract The transposase of 1S30 catalyses different transposi-
tional rearrangements via the dimer (IS30)2 intermediate 
structure. Mutation analysis provides evidence that the C-
terminal part of IS30 transposase is required for the formation 
and dissolution of (IS30)2 dimer. C-terminal mutants are also 
defective in transpositional fusion; however, this deficiency can 
be 'suppressed' by addition of the final product of site-specific 
dimerisation, the core (ISJ0)2 intermediate structure. The 
transposase part studied shows significant homologies in three 
highly conserved regions to proteins of IS50-related mobile 
elements. 
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1. Introduction 
The mobile element IS30 (Fig. 1A) is resident in the genome 
of Escherichia coli K-12 and C strains [1]. The 1221-bp-long 
insertion sequence contains one large open reading frame 
(ORF-A, 63-1212 bp), which is transcribed from the P30A 
promoter [2] and codes for the 44.3-kDa transposase [3]. 
The 17-kDa N-terminal part of the protein, the product of 
a truncated gene {ORF-A-N), was found to bind specifically to 
the terminal inverted repeats (IR) of the element [4]. IS30 has 
a pronounced, dual target specificity; not only well-character-
ised 'natural ' hot spots but its own IRs are recognised as 
targets (Olasz et al., manuscript submitted). 
The transposition of IS30 is a conservative process that 
proceeds through an (ISifTh intermediate [5]. To avoid any 
misunderstanding, a new terminology was used for transposi-
tional reactions mediated by IS50 (Fig. IB, [5]). The introduc-
tion of the term 'transpositional fusion' instead of co-integra-
tion seemed to be evident, since IS30 is not duplicated in this 
reaction. Accordingly, to distinguish the two site-specific dele-
tion processes that result in the formation and segregation of 
the (IS30)2 dimer, these reactions were designated by the new 
terms 'site-specific dimerisation' and 'dimer dissolution', re-
spectively. 
The intermediate structure, which plays a central role in the 
transposition of IS30, is formed by site-specific dimerisation 
(Fig. IB) so that the left and right IRs of two elements join to 
each other [6]. This structure is frequently produced from 
composite transposons and, in general, from D N A segments 
that carry two \S30 elements [5]. The dimer structure is highly 
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unstable and generates a burst of transpositional rearrange-
ments. (IS)2-like transpositional intermediates have also been 
observed with IS27 [7] and IS2 [8]. 
Similar to the homologous proteins of other insertion se-
quences, IS30 transposase is likely to be involved in several 
reactions: in recognition of the terminal inverted repeats of 
the element, and in cutting and joining of the termini to the 
transpositional target that also requires specific recognition 
and cleavage of the target sequences (for review see [9]; 
[10]). A detailed study of transposase domains enables one 
to obtain insight into the structural and functional organisa-
tion of the protein and into the transposition process itself. 
We present here experimental evidence that another puta-
tive domain, the C-terminal region of IS^O transposase, is 
responsible for the formation and dissolution of (IS30)2 inter-
mediates. 
2. Materials and methods 
2.1. Media, enzymes, chemicals and DNA techniques 
LB medium was prepared as described by Miller [11]. Restriction 
endonucleases, T4 DNA ligase and DNA polymerase I Klenow frag-
ment were obtained from Boehringer Mannheim (Germany) and Min-
otech (Greece). Antibiotics (Sigma, Germany) were used at final con-
centrations: kanamycin (Km) 20 ug/ml; ampicillin (Ap) 200 ug/ml; 
chloramphenicol (Cm) 20 ug/ml. [35S]dATP was obtained from Amer-
sham (UK). Sequencing was performed with the chain termination 
method of Sanger et al. [12] using the T7 sequencing kit of Pharmacia 
(Sweden). Commonly used DNA techniques were carried out accord-
ing to Sambrook et al. [13]. 
2.2. Plasmid constructs 
In the transpositional fusion experiments two groups of plasmids 
were distinguished: the donor plasmids were pACYC177 [14] deriva-
tives and were able to produce IS50 transposase, while the target 
plasmids contained preferred target sequences (hot spots) cloned 
into a pEMBL vector [15]. The structure and relevant properties of 
the plasmids are shown in Figs. 2 and 3. 
2.2.1. Target plasmids. pAW782 and pAW1016 carried hot spots 
derived from bacteriophages lambda (LHS) and PI (P1HS), respec-
tively [5]. pAW758 and pAW1105 contained the right IR of IS30 
joined to the lambda hot spot region (LHS-RIR) and the core 
(IS30)2 structure, respectively (Olasz et al., manuscript submitted). 
2.2.2. Donor plasmids. The structures of plasmids pAW472, 
pAW1019, pAW1020, pAW1026, pAW1027, pAW1152 and 
pAW1180 are described in Section 3 and presented in Fig. 2. The 
construction of pTFA89 and pTFA91 (Fig. 2): a new EcoRl site 
was introduced in the right IR of the element by inserting an addi-
tional T base into IS30 position 1216. The in vitro mutagenesis 
(Amersham, RPN 1523) was carried out on a template containing 
an intact 1S30 element (pAW1038 [5]) using the following mutant 
oligonucleotide: GACAGATTGAATTCTACAGCCTGC. The Hin-
dlll-ZscoRI fragment of the mutant IS30 (positions 459-1216) was 
inserted into the //!«dIII-£coRI site of pBluescript II KS+ (Strata-
gene), and the CmR marker gene from pAW302 [16] was cloned ad-
jacent to the truncated RIR. In the final step, the Ncol fragments of 
pAW1026 and pAW1019, containing the right end-CmR gene junc-
tion, were replaced with the Ncol fragment of the newly constructed 
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plasmid. Since the latter segment carried the right IS30 end until the 
newly introduced EcoRI site (position 1216) the progeny control plas-
mids pTFA89 and pTFA91 were able to produce intact transposase 
protein, but their 'inner' right IRs were truncated and inactive in 
transposition (data not shown). 
The structures of pAW1137 [5], pAW1158, pFOL3, pFOL4 and 
pFOL6 are described in Section 3 and shown in Fig. 4. 
2.3. Transpositional fusion experiments 
The method to detect rare transposition events with the aid 
of mobilizable target plasmids and the helper phage R408 was de-
scribed earlier [5]. In these experiments the donor plasmid was intro-
duced into the recA~ JM109 [17] host already harbouring a target 
plasmid. After incubation bacteria were infected with the helper phage 
R408, target plasmids and their rearrangement derivatives were 
packed into phage particles that were used to infect new JM109 
host. Applying appropriate selection (donor plasmids: KmRCmR, tar-
get plasmids: ApR) fusion products were detected as CmRKmRApR 
colonies. 
2.4. Detection of site-specific dimerisation and dimer dissolution 
Plasmids pAW1026, pAW1027, pAW1137, pFOL3, pFOL4 and 
pTFA89, respectively, were introduced into the recA~ strain JM109, 
and transformants were selected for the resistance markers carried by 
the vector (KmR) and the transposable element (CmR). In each experi-
ment at least five transformant colonies were grown in LB under 
selection for KmR. From these cultures overnight subcultures were 
subsequently inoculated several times with the same selection. After 
each passage plasmid DNA was purified from an aliquot and was 
used for the transformation of JM109. The number of KmRCms 
and KmRCmR transformants was determined by replica plating. 
The frequency of Cms segregants was determined as the ratio of 
KmRCms colonies versus total number of KmR colonies. In each 
experiment plasmid DNA was purified from at least 10 KmRCms 
colonies and was analysed with restriction endonucleases. The ratio 
of confirmed segregants versus total tested KmRCms colonies 
was used for the correction of the frequency data (Fig. 4). In the 
stability assay of pAW1137 and its derivatives, the expression of the 
transposase gene from the tac promoter was induced with 0.1 mM 
IPTG. 
3. Results 
3.1. Functional analysis of mutations affecting the IS30 
transposase protein 
To determine the role of the C-terminal part of the IS30 
transposase protein, mutations were introduced in this region 
and their effect was investigated in different transpositional 
reactions. In the first set of experiments the chloramphenicol 
resistance marker gene (CmR) was cloned into the donor plas-
mids, into the BgKI site of IS30. In the resulting plasmid 
pAW1019 the two inverted repeats of the element are intact, 
but the last 31 amino acids of the transposase are substituted 
by 25 unrelated amino acids (Fig. 2A). Additional mutagene-
sis was carried out in pAW1019 to produce the isogenic de-
rivatives pAW1020 and pAW1180 (Fig. 2A). The control plas-
mid pTFA91, which was also analogous structurally, 
contained the intact IS30 transposase gene, but the last 5 bp 
of the element were deleted and the 'inner' right IR was there-
fore inactive in transposition (see Section 2.2.). 
In the transpositional fusion experiment (Fig. 2A) the ele-
ment producing the wild-type 1S30 transposase (pTFA91) was 
active with all the target plasmids. In contrast, no fusion 
product was detectable in the reaction of the donor plasmid 
carrying the BgUl* mutation in ORF-A (pAW1019) and the 
target plasmids containing hot-spot sequences from phages 
lambda (LHS) or PI (P1HS), and the right IS30 IR joined 
to LHS (LHS-RIR). However, this donor plasmid was active 
with the joined IS30 ends that correspond to the core region 
of the (IS30)2 intermediate structure. In this case, the fre-
quency of rearrangement was about 4-fold lower than with 
the control plasmid pTFA91. Structural analysis revealed that 
the right and left IR of pAW1019 interacted with the core 
(IS50)2 structure with about equal probability (LIR: 9/16 
cases, RIR: 7/16 cases). All 16 independent isolates were 
transpositional fusion products (Fig. 3A). No simple trans-
position or any other type of rearrangement was observed 
in this experiment. According to our data, introduction of a 
mutation at the BgKI site of 1S30 (1115 bp position) has 
abolished the ability of the element to undergo transposition; 
activity was only observed with the target consisting of the 
core (IS30)2 structure. 
The Xbal* mutant, in which the filling-in of the unique 
Xbal site (965 bp position) affected the last 81 amino acids 
in the C-terminal part of IS30 transposase, was functionally 
similar to the Bglll* mutant, but the frequency of rearrange-
ments was 3-4-fold lower in the presence of joined IRs 
(pAW1020, Fig. 2A). The structure of the rearranged prod-
ucts was analogous to those described for pAW1019. 
The A^col* mutation contains a deletion that creates a TAA 
stop codon in ORF-A at position 354 bp. The construct car-
rying this mutation (pAW1180) did not reveal any activity 
with the four target sequences tested, including the joined 
ends of IS30; therefore the Ncol* mutant was considered as 
a negative control. 
Since no complementation was observed with the transpo-
sase expressed from the four genomic IS30 copies of JM109 
(see donor pAW1180), the DNA rearrangements were obvi-
ously catalysed by the mutant IS30 transposases encoded on 
the donor plasmids. The stability of the wild-type and mutant 
transposase proteins was also examined (data not shown), and 
no detectable differences were found; therefore it is unlikely 
that the reduced half-lives of the truncated proteins would be 
responsible for the changes in the transpositional activities of 
the mutants. 
Fig. 1. The structure (A) and simplified transpositional model (B) of IS30. The element is shown as a large box. The 26-bp-long left (LIR) and 
right (RIR) inverted repeats are illustrated as blank and filled triangles, respectively. The coordinates of the first and last nucleotides are given 
below the element, while the recognition sites of relevant restriction endonucleases are marked by small arrows: BgKI (Bg); Hindlll (H); Ncol 
(Nc); Xbal (X). The ORF of 1S30 transposase (ORF-A, horizontal arrow) is expressed from the P30A promoter (black arrowhead), the first 
and last amino acids (aa) of the protein are given. Asterisks and a small box above ORF-A show the location of investigated mutations: 
Ncol*, Xbal*, and Bglll*. The truncated transposase protein expressed from ORF-A-N binds to the IRs of IS30. The simplified transpositional 
model of 1S30 mediated DNA rearrangements (B). Duplication of ISiO means different, non-transpositional reactions that result in the presence 
of two 1S30 copies on the same replicon: e.g. homologous recombination between two IS30 carrying replicon that leads to the formation of a 
dimer replicon (for the detailed model and transpositional steps see [5]). Similarly, the presence of a composite transposon represents the same 
topology. The (1S30)2 intermediate is formed by site-specific dimerisation, and induces further inter- and intramolecular reactions. The recon-
struction of the original structure via the dissolution of the dimer provides the possibility for further cycles. The target region for transposition 
is shown as a blank circle, the site of insertion is represented by a vertical line. The different regions of the vector molecule were marked (a, b, 
c and d). 
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Fig. 2. Effect of C-terminal mutations in the IS30 transposase gene on transpositional fusion reactions. Transpositional frequencies were meas-
ured between donor plasmids producing wild-type or mutant 1S30 transposases and plasmids containing different target regions: lambda and 
Pl-derived hot spots; LHS-RIR or (IS30)2*. The latter designates to the joined IRs, the core intermediate structure. In the wild-type donor 
replicons the ORF-A is intact, but the 'inner' right IR of the element was truncated (small filled triangle) and therefore inactive in transposition 
(see Section 2.2.). Data represent the average values of at least five independent experiments (see Section 2.3.). n.d. = not determined; aa: amino 
acid. Indicated amino acid positions refer to wild-type transposase sequence. Asterisks above the schematic structures show the location of ad-
ditional mutations. For other symbols see Fig. 1. 
3.2. Joined IS30 IRs carried in cis can suppress mutations in 
the C-terminal region of IS30 transposase 
The phenomenon, that the BgKl* mutant displayed trans-
positional activity when the target plasmid carried the core 
(IS30)2 structure in trans, incited us to insert joined IRs into 
the donor plasmid (see pAW1026 and pAW1027, Fig. 2B). 
The new set of donor plasmids was therefore analogous to 
pAW1019, but they contained the core intermediate structure 
in cis. 
Donor plasmids containing only the BglU* mutation 
(pAW1026 and pAW1027) mediated transpositional fusions 
not only with the joined IRs of IS30 (pAW1105) but also 
with the previously inactive targets. The BgKl* mutant re-
sulted in about a 2-3-fold lower transpositional activity than 
the wild type when they were carried in a comparable struc-
ture (pAW1026 and pTFA89, Fig. 2B. Note that pTFA89, 
similarly to pTFA91, contains the intact ORF-A, but the 'in-
ner' RIR of the element is truncated.). The two BglU* mu-
tants (pAW1026 and pAW1027) differing in the location of 
the (IS30)2 structure showed identical pattern in their trans-
positional frequencies with the offered target sequences; how-
ever, pAW1026 was almost twice as active. Note that this 
pattern is significantly different from what we observed be-
tween pAW1019 and the same targets. These findings indicate 
that the presence of the joined IRs can considerably suppress 
the effect of mutations in the C-terminal region of 1S30 trans-
posase regardless of its location. 
Several rearrangement products of pAW1026 were analysed 
and their structure showed that they were formed by the in-
teractions of the joined IS30 ends carried by the donor plas-
mid and the offered target (Fig. 3B-D). The sequence analysis 
of both junctions in four independent pAW782-pAW1026 
fusion products revealed that 2 bp of the target sequence 
had been duplicated while the 2 bp separating the joined 
IRs of IS30 on plasmid pAW1026 had been lost upon the 
reaction. It demonstrates that this transpositional fusion is a 
conservative process as was described by Olasz et al. [5]. 
Introducing additional mutations into the ORF-A of the 
BglU* mutant pAW1026 we found that only the Xbal* mu-
tant mediated transpositional reactions with the targets, 
Fig. 3. Schematic illustration of experimentally identified transpositional reactions mediated by donor plamids presented in Fig. 2A,B. Charac-
teristic interactions between the transposase producing plasmids (pAW1019 and pAW1026) and target replicons containing (ISiffh*, i.e. the 
joined IRs, lambda hot spot (LHS), PI hot spot (PIHS) and LHS-RIR sequence are shown in A, B, C and D, respectively. LHS and PIHS 
are represented by a blank circle, LHS-RIR as a half circle joining to the right IR. The inverted repeats of the element are numbered. CmR: 
chloramphenicol resistance marker (chloramphenicol acetyltransferase); KmR: kanamycin resistance marker (aminoglycoside-3'-phosphotransfer-
ase); ApR : ampicillin resistance marker ((3-lactamase). Thin line: pACYC177 derivatives; thick line: pEMBL18 or pEMBL19 derivatives; dou-
ble line: CmR gene. For other symbols and abbreviations see Figs. 1 and 2. 
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Fig. 4. The intact C-terminal part of IS30 is responsible for dimer dissolution (A) and site-specific dimerisation (B). The frequency of segrega-
tion was measured in both experiments as described in Section 2. One passage represents an overnight culture. pTFA89 and its C-terminal mu-
tant derivatives (A) are carrying the joined terminal inverted repeats of IS30 and an additional 1S30 end as a structural requirement for dimer 
dissolution. The most preferred segregation pathway of pTFA89, the loss of the element carrying the CmR marker, is presented. pAW1137 and 
its mutant derivatives (B) contain the left and right IRs of 1S30 separated by the CmR gene. ORF-A was placed under the control of the induc-
ible tac promoter (small blank arrowhead). The characteristic reaction of the plasmid, the formation of (ISJ?0)2-like intermediate is shown. After 
the third passage IPTG was added in a final concentration of 0.1 mM in order to induce the expression of the transposase gene. For other 
symbols and abbreviations see Figs. 1 and 2. 
although the frequency of rearrangements was lCMO-fold 
lower in this case than with pAW1026 (Fig. 2B). This obser-
vation suggests that in the presence of the core intermediate 
structure the amino acid positions 303-353 are important, but 
not absolutely required for the transposition of the element. 
The Ncol* mutant proved to be inactive in this experiments as 
well. 
From the data discussed so far we draw the following con-
clusion: if the mutation affects the last 31-81 C-terminal ami-
no acids of the protein, transpositional fusion is only observed 
in the presence of the two joined IRs of IS30. Therefore, 
according to our results, the core (IS50)2 structure can sup-
press the effect of mutations in the C-terminal region of IS30 
transposase. 
3.3. Dimer dissolution is defective in the C-terminal mutants of 
IS30 transposase 
One characteristic of the wild-type intermediate is the high 
degree of instability, since it rapidly segregates by means of 
dimer dissolution to result in a product that carries only one 
1S30 element (Fig. IB, [5]). Plasmids pTFA89, pAW1026 and 
pAW1027 (see Fig. 2B) have the structural requirements to 
form such site-specific deletions (see Fig. 4A). 
The ability of wild-type and mutant transposase to mediate 
dimer dissolution was investigated (Fig. 4A). In the control 
plasmid, which contained the intact transposase gene 
(pTFA89), loss of the element was observed at high frequen-
cies, up to 65%. The most abundant segregant that repre-
sented more than 90% of the products is shown in Fig. 4A 
(pAW1158), while minor segregation products were identified 
as deletions, inversions or bacteria without detectable plas-
mids. 
On the contrary, the BgM* mutant plasmids pAW1026 and 
pAW1027 (see Fig. 2B), which were also expected to yield the 
same or analogous segregation products, were stable and no 
segregants were found even after four passages. In this case, 
the frequency of dimer dissolution was at least 400-fold lower 
than with the control plasmid. 
The integrity of the C-terminal of 1S30 transposase is there-
fore essential for the dissolution of the intermediate structure. 
3.4. Site-specific dimerisation is blocked in the C-terminal 
mutants 
(ISJ0)2 intermediate is formed by the site-specific deletion 
of the DNA segment located between two IS30 elements car-
ried on the same replicon (Fig. IB, [5]). pAW1137, which 
contains the intact transposase gene under the control of the 
inducible tac promoter, was constructed to study this process 
(Fig. 4B): the IRs present in the plasmid join to each other to 
form an (IS30)2-like intermediate (see pFOL6 in Fig. 4B). 
The stability of pAW1137 and its mutant derivatives was 
monitored upon induction of transposase gene expression. Ex-
perimental data demonstrated that pAW1137, the control 
plasmid encoding the wild-type transposase, was very unsta-
ble ; the frequency of segregation was 2-3% without induction 
(Fig. 4B, passages 1-3) and raised to 50% upon induction 
(Fig. 4B, passages 4-5). On the contrary, plasmids pFOL3 
and pFOL4, which resulted from pAW1137 by filling-in the 
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SLNGRPRKTL NVJHSPLQVLA QVLAHPT^PL PVO Vi 
E1.N7RPRKRF NWKCP1EVMT EVVALQJOA? ASIO. ' 
Wr.NLRPR^GL GFRG/PVKVF^ EYP.GAA :.3F 
:-::,NHKPRKRL CYLTPHEKFX C I I 3 0 K S V A F AS w 
VIINARPMKTL. NVJQSPRKFFO CFTVFC- "ic-: 
A l N E R r R R I H GYQSAKFJ.F3 I.TQTA U". 
W1NHYPKRLF NYKSPVFM 7, F T.ANFMLKFAK P. lit. 
ORSEilPRKST, N Y R T P I E 7 F L HYVUiiAl-VL-N L I j l ) 
VTMDKT.RPCI. NWISSKEHl-'L y l j l ; > : 
XRSlHIPaKSL HYK,rPIEVi ' ,L S[!IC?.EEJ.,SN :.T i l l 
T D Q E F R f i l S N HGL X 
region I I 
1 S 3 0 ;8S KSjTMGRGME L.ARKLEFTVF, TGVKVYFCDP CSPWO/RGTNE MTWGL1R0.Y FPKKTOLJWJY TCHFr.Cl.VAA 
Hglll* ;as KSLTWDRGKE EASHT.FFTVS TGVKVYFCSP QSPWQRGTNE NTNGLIRQ.Y FPKKTCUACV TCFJFT.D :n-j 
Xbal* ;ss KS1TWDRGKE GA3Hr MI 
H PHK I. N 
region III 
Q:,NNR?RFTL XFKTPKE.: 
Fig. 5. Homology between the C-terminal regions of IS50-related transposases. Asterisks mark the highly conserved amino acids: *, similarity 
(at least 8 of 11 amino acids were identical in the given position); **, identity in all 11 proteins. Regions I, II and III (shaded) are referring to 
conserved stretches of amino acid sequences. The consensus sequence of each region is presented. The C-terminal part of the Xbal* and BgM* 
IS50 transposase mutants is shown below the wild-type protein. The references for the presented amino acid sequences are the following: 
IS/036 [18]; IS1394 [19]; ISA2 [20]; IS4351 [21]; IS1070 [22]; IS1161 [23]; IS/239 [24]; IS6770 [25]; Spvl: ORF3 protein of the single-stranded 
virus [26]; IS/062 [27]; IS30 [3]. The alignment was made by the GCG program package [28]. 
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unique BgUl and Xbal sites, respectively, remained stable dur-
ing prolonged growth. Only a few KmRCm s derivatives were 
found in their segregation tests (pFOL3: 11/4570; pFOL4: 9/ 
5308 colonies), and they were mostly point or deletion mu-
tants in the CmR gene. However, four pFOL6-type plasmids 
were also found among the segregants of pFOL3, which con-
tains the BgUl* mutation, but they all derived from one of the 
five parallel experiments. Possibly, the Bglll* mutant either 
retained a small residual activity or it was complemented by 
the host-resident copies of the element, although it should be 
mentioned here that the Bglll* mutant did not show any 
residual activity in dimer dissolution (Fig. 4A). 
The very high stability of the plasmids carrying mutations 
in the C-terminal part of the IS30 transposase indicates that 
an intact C-terminus is required for site-specific dimerisation 
that leads to the formation of (IS30)2 intermediates. 
4. Discussion 
The mutant analysis described in this paper shows that the 
C-terminal part of the 1S30 transposase is involved in various 
transpositional rearrangements. The introduction of muta-
tions in this region abolished the ability of the element to 
mediate site-specific dimerisation, dimer dissolution and trans-
positional fusion. However, the deficiency in transpositional 
fusion can be surpassed by the presence of the core (1S30)2 
structure. This special kind of suppression, where the addition 
of a structure leads to regaining a function, was observed both 
in trans (Fig. 2A) and in cis (Fig. 2B). A construct containing 
only one IS30 IR (LHS-RIR, see pAW758, Fig. 2A) was 
unable to substitute the core (1S30)2 intermediate and there-
fore to suppress the effect of mutations in the C-terminal 
region. 
The fact that the effect of mutations in the C-terminal of 
the 1S30 transposase is surpassed by the presence of the core 
(ISiO)2 structure suggests that this part of the protein is re-
sponsible for the joining of the IRs, i.e. for site-specific dimer-
isation. According to this hypothesis the formation of (ISiO)2 
dimer should be affected by the C-terminal mutations — as 
was verified experimentally (Fig. 4B). The phenomenon that 
C-terminal mutants are defective both in site-specific dimer-
isation and dimer dissolution can refer to the common nature 
of these processes. Indeed, these reactions represent site-spe-
cific deletions between the IRs of the element [5]. It is also 
worthwile to mention in this context that dimer dissolution 
occurs roughly 1000-fold greater efficiency than transposition-
al fusion. 
The specificity of the C-terminal mutations is strongly sug-
gested by the fact that the various types of reactions were not 
affected to the same extent. This conclusion is based on com-
parison of the transpositional frequencies mediated by the 
Bglll* mutant and wild-type control in different reactions. 
In the experiment presented in Fig. 2A, the activity of the 
Bglll* mutant was reduced compared to the wild type at least 
8-15-fold with all the targets, except the core (ISJ0)2 struc-
ture, for which the decrease was only 4-fold. Note that the 
difference can be more significant, since no transpositional 
fusion product was detected at all with the targets LHS, 
P1HS and LHS-RIR, although we reached the detection limit 
of the system (transpositional frequency is lower than 10~9). 
The suppression effect of the core intermediate structure was 
detected both in trans and in cis. When the core (IS50)2 struc-
ture was situated in the donor replicon (Fig. 2B), the differ-
ence between the activities of the Bglll* mutant and wild-type 
constructs was uniformly 2-3-fold with all the targets. This 
level corresponded to what was observed when the donor 
replicon carried no (IS30)2 structure, and joined IRs were 
present only on the target molecule, i.e. in trans (pAW1105, 
Fig. 2A). These findings confirm the specific function of the C-
terminal part of IS30 transposase, namely formation of the 
(IS50)2 dimer. Indeed, in the experiments focusing on dimer 
dissolution (Fig. 4A) and site-specific dimerisation (Fig. 4B), 
the Bglll* mutant was about 200-fold less active. These ob-
servations rule out the possibility that the C-terminal mutants 
of 1S30 transposase reduces the transpositional ability in gen-
eral. If this hypothesis were true, all types of reactions should 
be affected to about the same extent, in contrast with the data 
presented above. 
Comparing the amino acid sequences of the transposases of 
1S30 and related IS elements (listed in Fig. 5), the C-terminal 
region reveals to be highly conserved, as has already been 
described by Dong et al. [18], Vaughan and de Vos [22], Ka-
pur et al. [24] and Yeo and Poh [19]. This part of the trans-
posases show a 51% similarity and 40% identity to IS30 trans-
posase in average. The corresponding values for the remaining 
part are 37% similarity and 28% identity. The conserved ami-
no acid residues in the C-terminal part of the proteins are 
concentrated in three major regions that may be considered 
as domains. While region I correspond to the N3 motif (D-x-
G/A-x-x-Y/F, [29]), which was found in transposases of vari-
ous origins; the other two regions show no significant homol-
ogy to known motifs. The observation that the frequencies of 
rearrangements were about one order of magnitude higher in 
the case of the Bglll* mutant compared to the Xbal* mutant 
(Fig. 2B) might be related to the fact that the Bglll* mutation 
affects only region III, while in the Xbal* mutant regions II 
and III were both destroyed. However, at this stage of the 
investigations other explanations cannot be ruled out. 
Further genetical and biochemical analysis of the C-termi-
nus can clarify the molecular mechanism of intermediate for-
mation, which is required for the efficient transposition of 
IS30 and other (IS)2-forming insertion sequences. 
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